Table 2.
Survival analysis in diverse metastatic organs.
| Parameter | 1-year OS (%) | Univariate analysis | 1-year CSS (%) | Univariate analysis | ||
|---|---|---|---|---|---|---|
| Log rank χ2 test | P | Log rank χ2 test | P | |||
| Bone | ||||||
| No metastasis | 50.8 | 12615.144 | <0.001 | 57.5 | 13549.160 | <0.001 |
| Metastasis | 20.0 | 25.9 | ||||
| Brain | ||||||
| No metastasis | 48.4 | 6499.456 | <0.001 | 55.1 | 7316.606 | <0.001 |
| Metastasis | 22.1 | 27.4 | ||||
| Liver | ||||||
| No metastasis | 49.2 | 14245.964 | <0.001 | 55.8 | 14802.929 | <0.001 |
| Metastasis | 13.6 | 20.1 | ||||
| Distant lymph nodes | ||||||
| No metastasis | 46.4 | 2748.753 | <0.001 | 53.0 | 2990.572 | <0.001 |
| Metastasis | 22.9 | 28.8 | ||||
OS, Overall Survival; CSS, Cancer Specific Survival.